Clinical Trial Update: IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating intravenous ibuprofen for post-electroconvulsive therapy myalgia was terminated, and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Myalgia

Drugs mentioned

• Ibuprofen (IV) (ibuprofen)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Depression, Myalgia | Phase 4 | Status: TERMINATED | Results posted: 2016-11-18